Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 β gene and promoter in late onset Alzheimer's disease
Open Access
- 27 April 2001
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 6 (3) , 320-324
- https://doi.org/10.1038/sj.mp.4000852
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Diabetes mellitus and the risk of dementiaNeurology, 1999
- Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin,a component of the presenilin protein complexNature Medicine, 1999
- Distribution, Levels, and Activity of Glycogen Synthase Kinase-3 in the Alzheimer Disease BrainJournal of Neuropathology and Experimental Neurology, 1997
- Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK IIActa Neuropathologica, 1996
- Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cellsNeuroscience Letters, 1995
- Modulation of PHF-like tau phosphorylation in cultured neurones and transfected cellsNeurobiology of Aging, 1995
- Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cellsCurrent Biology, 1994
- Molecular Genetics of Alzheimer's DiseaseArchives of Neurology, 1993
- Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA.The Journal of cell biology, 1989
- Tau protein function in living cells.The Journal of cell biology, 1986